ARTICLE | Clinical News
Abelcet liposomal amphotericin B regulatory update
November 8, 1999 8:00 AM UTC
Turkey granted marketing approval to LIPO's Abelcet to treat invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy. ...